986 related articles for article (PubMed ID: 25803181)
21. Congo red-positive cardiac kappa-AL amyloidosis in plasmacytoma -- case report and review of the literature.
Tzankov A; Pölzl G; Mairinger T
Acta Med Austriaca; 2003; 30(1):29-32. PubMed ID: 12558564
[TBL] [Abstract][Full Text] [Related]
22. [Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality].
Loforte A; Pilato E; Martin Suarez S; Folesani G; Jafrancesco G; Castrovinci S; Cefarelli M; Potena L; Magnani G; Grigioni F; Caramelli F; Frascaroli G; Di Bartolomeo R; Marinelli G
G Ital Cardiol (Rome); 2014 Oct; 15(10):577-85. PubMed ID: 25424022
[TBL] [Abstract][Full Text] [Related]
23. [Amyloid cardiomyopathy: a link between cardiology and hematology. A case report of positive response to standard therapy].
Petrillo G; Catalano L; Petruzziello F; Padula S; Petrillo C; Caso P
G Ital Cardiol (Rome); 2007 Jun; 8(6):371-6. PubMed ID: 17633911
[TBL] [Abstract][Full Text] [Related]
24. Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy.
Tomberli B; Cappelli F; Perfetto F; Olivotto I
JAMA Cardiol; 2017 Jan; 2(1):94-97. PubMed ID: 27806176
[TBL] [Abstract][Full Text] [Related]
25. Application of the Age, Creatinine, and Left Ventricular Ejection Fraction Score for Patients on Extracorporeal Membrane Oxygenation.
Tsai TY; Tsai FC; Fan PC; Chang CH; Lin CY; Chang WW; Lee SY; Hsu HH; Tian YC; Fang JT; Yang CW; Chen YC
Artif Organs; 2017 Feb; 41(2):146-152. PubMed ID: 27580634
[TBL] [Abstract][Full Text] [Related]
26. Veno-veno-arterial extracorporeal membrane oxygenation for respiratory failure with severe haemodynamic impairment: technique and early outcomes.
Ius F; Sommer W; Tudorache I; Avsar M; Siemeni T; Salman J; Puntigam J; Optenhoefel J; Greer M; Welte T; Wiesner O; Haverich A; Hoeper M; Kuehn C; Warnecke G
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):761-7. PubMed ID: 25736272
[TBL] [Abstract][Full Text] [Related]
27. [Primary cardiac amyloidosis -- condition which can be diagnosed by a cardiologist].
Zielińska M; Koniarek W; Kaczmarek K; Maciejewski M; Wagrowska-Danilewicz M; Goch JH
Kardiol Pol; 2006 May; 64(5):517-21. PubMed ID: 16752338
[TBL] [Abstract][Full Text] [Related]
28. [The rapid progress of heart failure due to systemic amyloidosis with cardiac involvement--case report].
Gilowski W; Stryjewski P; Gilowska M; Liszniański P; Nowak J
Przegl Lek; 2015; 72(11):697-700. PubMed ID: 27012134
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2013 May; 88(5):416-25. PubMed ID: 23605846
[TBL] [Abstract][Full Text] [Related]
30. [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma].
Rekhtina IG; Zakharova EV; Stolyarevich ES; Sinitsina MN; Denisova EN
Ter Arkh; 2015; 87(6):98-101. PubMed ID: 26281203
[TBL] [Abstract][Full Text] [Related]
31. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic factors in light chain amyloidosis].
Jávorniczky NR; Bodó I; Masszi T; Mikala G
Orv Hetil; 2015 Sep; 156(39):1577-84. PubMed ID: 26550915
[TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2016 Sep; 91(9):947-56. PubMed ID: 27527836
[TBL] [Abstract][Full Text] [Related]
34. Blade and balloon atrial septostomy for left heart decompression in patients with severe ventricular dysfunction on extracorporeal membrane oxygenation.
Seib PM; Faulkner SC; Erickson CC; Van Devanter SH; Harrell JE; Fasules JW; Frazier EA; Morrow WR
Catheter Cardiovasc Interv; 1999 Feb; 46(2):179-86. PubMed ID: 10348539
[TBL] [Abstract][Full Text] [Related]
35. Massive systemic amyloidosis associated with light-chain deposition disease.
Troussard X; Hurault de Ligny B; Gallet B; Ganeval D; Mandard JC; Ryckelynck JP; Leporrier M
Nephron; 1989; 52(2):139-43. PubMed ID: 2500613
[TBL] [Abstract][Full Text] [Related]
36. Extracorporeal Membrane Oxygenation Can Save Lives in Children With Heart or Lung Failure After Liver Transplantation.
Jean S; Chardot C; Oualha M; Capito C; Bustarret O; Pouard P; Renolleau S; Lacaille F; Dupic L
Artif Organs; 2017 Sep; 41(9):862-865. PubMed ID: 28925053
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal membrane oxygenation support as a bridge to pediatric heart transplantation.
del Nido PJ; Armitage JM; Fricker FJ; Shaver M; Cipriani L; Dayal G; Park SC; Siewers RD
Circulation; 1994 Nov; 90(5 Pt 2):II66-9. PubMed ID: 7955285
[TBL] [Abstract][Full Text] [Related]
38. Extracorporeal membrane oxygenation for very high-risk transcatheter aortic valve implantation.
Seco M; Forrest P; Jackson SA; Martinez G; Andvik S; Bannon PG; Ng M; Fraser JF; Wilson MK; Vallely MP
Heart Lung Circ; 2014 Oct; 23(10):957-62. PubMed ID: 24954708
[TBL] [Abstract][Full Text] [Related]
39. An unusual heart failure: cardiac amyloidosis due to light-chain myeloma.
Martinelli N; Carleo P; Girelli D; Olivieri O
Circulation; 2011 May; 123(18):e583-4. PubMed ID: 21555719
[No Abstract] [Full Text] [Related]
40. Diagnostic approach to cardiac amyloidosis.
Amin HZ; Mori S; Sasaki N; Hirata K
Kobe J Med Sci; 2014 Jun; 60(1):E5-E11. PubMed ID: 25011639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
